|
HU195220B
(en)
*
|
1983-05-03 |
1988-04-28 |
Byk Gulden Lomberg Chem Fqb |
Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
|
|
DE3579436D1
(de)
*
|
1984-12-18 |
1990-10-04 |
Otsuka Pharma Co Ltd |
Tetrahydrochinolin- derivate, verfahren zu deren herstellung und diese enthaltende antimagengeschwuerzusammensetzungen.
|
|
KR950001015B1
(ko)
*
|
1986-01-10 |
1995-02-07 |
닛뽕 케미화 가부시끼가이샤 |
술폭시드 유도체의 제조방법
|
|
IT1222412B
(it)
*
|
1987-07-31 |
1990-09-05 |
Chiesi Farma Spa |
Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono
|
|
US5200407A
(en)
*
|
1989-06-29 |
1993-04-06 |
Meiji Seika Kaburhiki Kaisha |
Azole derivatives and anti-ulcerative composition containing same
|
|
JP2679745B2
(ja)
*
|
1989-06-29 |
1997-11-19 |
明治製菓株式会社 |
アゾール誘導体及びそれらを有効成分とする抗潰瘍剤
|
|
ZW1992A1
(en)
*
|
1991-02-25 |
1993-09-22 |
Janssen Pharmaceutica Nv |
4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
|
|
WO1993006097A1
(en)
*
|
1991-09-20 |
1993-04-01 |
Merck & Co., Inc. |
Novel process for the preparation of anti-ulcer agents
|
|
PT711282E
(pt)
*
|
1993-07-28 |
2002-11-29 |
Aventis Pharma Ltd |
Compostos inibidores de pde iv e de fnt
|
|
WO1998054172A1
(en)
*
|
1997-05-30 |
1998-12-03 |
Dr. Reddy's Research Foundation |
Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
|
|
WO2000000474A1
(en)
*
|
1998-06-26 |
2000-01-06 |
Russinsky Limited |
Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds
|
|
US6166213A
(en)
*
|
1998-08-11 |
2000-12-26 |
Merck & Co., Inc. |
Omeprazole process and compositions thereof
|
|
US6852739B1
(en)
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
|
US6316020B1
(en)
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
|
DE10140492A1
(de)
|
2001-08-17 |
2003-08-14 |
Gruenenthal Gmbh |
Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung
|
|
WO2004012659A2
(en)
*
|
2002-08-01 |
2004-02-12 |
Nitromed, Inc. |
Nitrosated proton pump inhibitors, compositions and methods of use
|
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
|
FR2845916B1
(fr)
*
|
2002-10-21 |
2006-07-07 |
Negma Gild |
Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
|
|
FR2845915B1
(fr)
|
2002-10-21 |
2006-06-23 |
Negma Gild |
Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
|
|
FR2845917B1
(fr)
|
2002-10-21 |
2006-07-07 |
Negma Gild |
Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
|
|
FR2848555B1
(fr)
|
2002-12-16 |
2006-07-28 |
Negma Gild |
Enantiomere(-)du tenatoprazole et son application en therapeutique
|
|
US20050220870A1
(en)
*
|
2003-02-20 |
2005-10-06 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
|
CA2512928A1
(en)
*
|
2003-02-24 |
2004-09-02 |
Mitsubishi Pharma Corporation |
The enantiomer of tenatoprazole and the use thereof in therapy
|
|
US7608625B2
(en)
*
|
2003-03-13 |
2009-10-27 |
Eisai R & D Management Co., Ltd. |
Method for treating bruxism and bruxism-related diseases
|
|
US8993599B2
(en)
*
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
MXPA06000529A
(es)
*
|
2003-07-18 |
2006-08-11 |
Santarus Inc |
Formulaciones farmaceuticas utiles para inhibir la secrecion de acido y metodos para elaborarlas y utilizarlas.
|
|
CA2531566C
(en)
*
|
2003-07-18 |
2013-05-07 |
Santarus, Inc. |
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
|
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
|
CA2554271A1
(en)
*
|
2004-02-10 |
2005-08-25 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
|
|
EP1742630A4
(en)
*
|
2004-04-16 |
2010-01-20 |
Santarus Inc |
COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND PROKINETIC AGENT
|
|
TW200606163A
(en)
*
|
2004-04-22 |
2006-02-16 |
Eisai Co Ltd |
Imidazopyridine compound
|
|
CA2563808A1
(en)
*
|
2004-04-28 |
2005-11-10 |
Altana Pharma Ag |
Dialkoxy-imidazopyridines derivatives
|
|
US8815916B2
(en)
*
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
US8906940B2
(en)
*
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
TW200613301A
(en)
*
|
2004-06-15 |
2006-05-01 |
Altana Pharma Ag |
Novel amino-halogen-imidazopyridines
|
|
FR2871800B1
(fr)
*
|
2004-06-17 |
2006-08-25 |
Sidem Pharma Sa Sa |
Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
|
|
CN100364989C
(zh)
*
|
2004-09-30 |
2008-01-30 |
江苏豪森药业股份有限公司 |
拉唑类衍生物及其盐和用途
|
|
US20080119510A1
(en)
*
|
2004-12-09 |
2008-05-22 |
Altana Pharma Ag |
Substituted Imidazo [4,5-B] Pyridines As Inhibitors Of Gastric Acid Secretion
|
|
US20070015782A1
(en)
|
2005-04-15 |
2007-01-18 |
Eisai Co., Ltd. |
Benzimidazole compound
|
|
US9040564B2
(en)
|
2005-04-28 |
2015-05-26 |
Eisai R&D Management Co., Ltd. |
Stabilized composition
|
|
US7601737B2
(en)
|
2005-07-26 |
2009-10-13 |
Nycomed Gmbh |
Isotopically substituted proton pump inhibitors
|
|
MX2008000901A
(es)
*
|
2005-07-26 |
2008-03-26 |
Nycomed Gmbh |
Inhibidores de bomba de protones isotopicamente sustituidos.
|
|
CN1982311B
(zh)
*
|
2005-12-13 |
2010-10-13 |
天津维智精细化工有限公司 |
2-巯基-5-甲氧基咪唑[4,5-b]并吡啶的合成工艺
|
|
CN100376574C
(zh)
*
|
2006-06-14 |
2008-03-26 |
浙江大学 |
泰妥拉唑的制备方法
|
|
US20100317689A1
(en)
*
|
2006-09-19 |
2010-12-16 |
Garst Michael E |
Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
|
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
|
GB2444593B
(en)
|
2006-10-05 |
2010-06-09 |
Santarus Inc |
Novel formulations for immediate release of proton pump inhibitors and methods of using these formulations
|
|
AU2007317561A1
(en)
|
2006-10-27 |
2008-05-15 |
The Curators Of The University Of Missouri |
Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
|
|
FR2909380B1
(fr)
*
|
2006-12-04 |
2009-02-20 |
Sidem Pharma Sa Sa |
Conglomerats de sels de potassium de tenatoprazole
|
|
CN101980700A
(zh)
|
2008-02-20 |
2011-02-23 |
密苏里大学董事会 |
包含奥美拉唑和兰索拉唑以及缓冲剂的组合的组合物及其使用方法
|
|
CN102725289B
(zh)
|
2009-07-07 |
2015-12-02 |
科学与工业研究委员会 |
用于制备亚砜化合物的连续流方法
|
|
CN104203938A
(zh)
|
2012-01-21 |
2014-12-10 |
朱比兰特生命科学有限公司 |
用于制备2-吡啶基甲基亚硫酰基苯并咪唑、它们的类似物和光学活性对映体的方法
|
|
EP4598528A1
(en)
|
2022-10-04 |
2025-08-13 |
Arsenil Zabirnyk |
Inhibition of aortic valve calcification
|